NantKwest Inc. | Mutual Funds
Mutual Funds that own NantKwest Inc.
American Funds Small Cap World Fund
1,887,290
2.38%
0
0.02%
06/30/2018
iShares Nasdaq Biotechnology ETF
900,369
1.13%
-11,781
0.03%
09/06/2018
American Funds Insurance Series - Global Small Cap Fund
773,700
0.98%
0
0.07%
06/30/2018
Vanguard Total Stock Market Index Fund
635,282
0.8%
0
0%
07/31/2018
iShares Russell 2000 ETF
623,101
0.79%
-333
0%
09/06/2018
Vanguard Extended Market Index Fund
383,561
0.48%
0
0%
07/31/2018
iShares Russell 2000 Value ETF
271,653
0.34%
0
0.01%
09/06/2018
Virtus Wealth Masters Fund
134,500
0.17%
39,016
0.64%
06/29/2018
Fidelity Spartan Extended Market Index Fund
116,232
0.15%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
76,001
0.1%
0
0%
07/31/2018
| Address |
3530 John Hopkins Court
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.nantkwest.com |
| Updated |
07/08/2019 |
| NantKwest, Inc. engages in the development of immunotherapies with a focus on harnessing the power of the innate immune system. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The firm operates through the following geographical segments: United States; Europe; and Other Non-U. |
